Loans
Loans
HomeNewsTrendsHealthHow COVID-19 smell, taste loss differs from common cold decoded

How COVID-19 smell, taste loss differs from common cold decoded

The findings lend weight to the theory that COVID-19 infects the brain and central nervous system.

August 19, 2020 / 11:26 IST

Although COVID-19 patients may lose their sense of smell, they can breathe freely, do not tend to have a runny or blocked nose, and cannot detect bitter or sweet tastes, a study published on August 19 has found. The study is the first to compare how people with COVID-19 smell and taste disorders differ from those with other causes of upper respiratory tract infections, according to the researchers, including those from the University of East Anglia (UEA) in the UK.

The researchers hope that their work could help develop smell and taste tests for fast COVID-19 screening - in primary care and emergency departments.

The findings, published in the journal Rhinology, lend weight to the theory that COVID-19 infects the brain and central nervous system.

"The loss of smell and taste is a prominent symptom of COVID-19, however, it is also a common symptom of having a bad cold,” said lead researcher Carl Philpott, a professor at UEA's Norwich Medical School.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“We wanted to find out exactly what differentiates COVID -19 smell loss with the kind of smell loss you might have with a cold and blocked-up nose," Philpott said.

The research team carried out smell and taste tests on 10 COVID-19 patients, 10 people with bad colds and a control group of 10 healthy people -- all matched for age and sex.

"We wanted to see if their smell and taste test scores could help discriminate between COVID-19 patients and those with a heavy cold,” Philpott said.

The researchers noted that COVID-19 behaves differently to other respiratory viruses, for example by causing the body's immune system to over-react, known as a cytokine storm, and by affecting the nervous system.

They found that smell loss was much more profound in the COVID-19 patents, and they were less able to identify smells, and were not able to identify bitter or sweet tastes.

The researchers said it was this loss of true taste which seemed to be present in the COVID-19 patients compared to those with a cold.

"This is very exciting because it means that smell and taste tests could be used to discriminate between COVID-19 patients and people with a regular cold or flu,” Philpott said.

"Although such tests could not replace formal diagnostic tools such as throat swabs, they could provide an alternative when conventional tests are not available or when rapid screening is needed -- particularly at the level of primary care, in emergency departments or at airports,” he added.

The study also shows that there are altogether different things going on when it comes to smell and taste loss for COVID-19 patients, compared to those with a bad cold, the researchers said.

Follow our full coverage on COVID-19 here.

PTI
first published: Aug 19, 2020 11:21 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347